Citeline

Communication Preference Center

Welcome to the Citeline Communications Preference Center

Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments.

View your individual communications preferences below.

To change your preferences, check the box corresponding to information you’d like to receive email notifications about. You'll receive updates on relevant products/services, thought leadership and industry insights, details on upcoming in-person and virtual events.

Marketing Preference

Business updates on Citeline and its portfolio of products and services
R&D intelligence on global clinical trials, investigators, trial sites, and drug development pipelines
Insights on finding, educating, engaging and enrolling clinical trial participants
Timely news on global clinical trial disclosure compliance management, policies and trends
Information on 3D digital anatomy model used in education, practice, research, industry and more
Real-life application of anatomy and physiology learning, plus Primal news, analysis and more
Pharmaceutical industry news and strategic insights into the global life sciences and biotechnology markets
*Citeline customers will continue to receive email updates on products/services per contractual and/or legal requirements.


To view our privacy notice please 
click here. 

Pharma Ignite is the marketing insights division of Citeline.
Our network of industry-leading analysts, editors and partners deliver fresh insights, powered by Citeline’s world renowned suite of products and services. We provide innovative thought leadership, lead generation, awareness campaigns, and market analysis. 
To manage Pharma Ignite Preferences please Click Here.

Evalute - Citeline's sister company - Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real-world data, and deep expertise to help you make portfolio decisions that drive growth.
To Manage Evaluate Preferences please Click Here.